Lv3
356 积分 2024-07-02 加入
Targeted and cytotoxic inhibitors used in the treatment of lung cancers
1天前
待确认
Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy
1天前
已完结
Pharmacological targeting of the cancer epigenome
3天前
已完结
A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs
23天前
已完结
Potency-Enhanced Peptidomimetic VHL Ligands with Improved Oral Bioavailability
23天前
已完结
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
23天前
已完结
Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia
27天前
已完结
Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein
27天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
27天前
已完结
A chemical approach for global protein knockdown from mice to non-human primates
27天前
已完结
皖公网安备34019202002308
